Literature DB >> 16735970

Postprandial glycaemia: a plea for the frequent use of delta postprandial glycaemia in the treatment of diabetic patients.

G Slama1, F Elgrably, A Sola, J Mbemba, E Larger.   

Abstract

Postprandial hyperglycaemia is a phenomenon often neglected by patients as well as doctors. While patients only voluntarily measure morning and preprandial capillary glycaemia, physicians do not encourage the measurement of anything further. The specific role of postprandial hyperglycaemia in the determination of late diabetes complications, such as micro- and macroangiopathy, remains controversial. It is however undeniable that the postprandial glycaemic excursion plays an important role in total hyperglycaemia reflected by an increase in glycated haemoglobin. The postprandial glycaemia measurement or, more appropriately, the postprandial glycaemic excursion (the difference between postprandial and preprandial glycaemia, also called the postprandial delta glycaemia), is important to measure and there are specific tools to correct it when abnormal. Postprandial delta glycaemia should lie between 30 and 50 mg/dl. It is thus suggested to measure it not necessarily on a daily basis, but when it is expected that the glycaemic couple, or "pre-postprandial couple", is high. The specific tools for treatment of postprandial hyperglycaemia can be dietetic (carbohydrate quantity reduction or ingestion of fiber-rich and/or low glycaemic index foods) or medicinal. Among the specific medicinal treatments are the alpha-glucosidase-inhibitors (which can be used for both type 1 and type 2 diabetic patients), glinides and fast-acting insulins. Rather than first treating fasting and interprandial hyperglycaemia, as has been commonly done by physicians, the authors recommend the simultaneous treatment of pre-, inter- and postprandial hyperglycaemia. The optimal time at which to evaluate postprandial glycaemia is approximately 1 h and 15 minutes for type 1 and type 2 diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16735970     DOI: 10.1016/s1262-3636(07)70268-9

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  8 in total

1.  Interindividual and intraindividual variations in postprandial glycemia peak time complicate precise recommendations for self-monitoring of glucose in persons with type 1 diabetes mellitus.

Authors:  Mette Dencker Johansen; Irene Gjerløv; Jens Sandahl Christiansen; Ole K Hejlesen
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

Review 2.  Food protein-derived bioactive peptides in management of type 2 diabetes.

Authors:  Prasad Patil; Surajit Mandal; Sudhir Kumar Tomar; Santosh Anand
Journal:  Eur J Nutr       Date:  2015-07-08       Impact factor: 5.614

3.  Premeal injection of rapid-acting insulin reduces postprandial glycemic excursions in type 1 diabetes.

Authors:  Yoeri M Luijf; Arianne C van Bon; Joost B Hoekstra; J Hans Devries
Journal:  Diabetes Care       Date:  2010-08-06       Impact factor: 19.112

4.  Inhibition of α-Glucosidase by Thiosulfinate as a Target for Glucose Modulation in Diabetic Rats.

Authors:  Abdulrahman L Al-Malki
Journal:  Evid Based Complement Alternat Med       Date:  2016-03-09       Impact factor: 2.629

5.  Dosakaya Juice Assuages Development of Sucrose Induced Impaired Glucose Tolerance and Imbalance in Antioxidant Defense.

Authors:  Dommati Anand Kumar; Pisupati S R Sweeya; Srishti Shukla; Sanga Venkata Anusha; Dasari Akshara; Kuncha Madhusudana; Ashok Kumar Tiwari
Journal:  Pharmacogn Mag       Date:  2015-10       Impact factor: 1.085

6.  Effect of boiling on the antidiabetic property of enzyme treated sheep milk casein.

Authors:  Farhath Jan; Santosh Kumar; Richa Jha
Journal:  Vet World       Date:  2016-10-28

7.  Mitigation of starch-induced postprandial glycemic spikes in rats by antioxidants-rich extract of Cicer arietinum Linn. seeds and sprouts.

Authors:  Ashok Kumar Tiwari; Chinthapatla Sahana; Amtul Zehra; Kuncha Madhusudana; Domati Anand Kumar; Sachin Bharat Agawane
Journal:  J Pharm Bioallied Sci       Date:  2013-10

8.  Postprandial anti-hyperglycemic activity of marine Streptomyces coelicoflavus SRBVIT13 mediated gold nanoparticles in streptozotocin induced diabetic male albino Wister rats.

Authors:  Sathyanarayanan Ravi Sathish Kumar; Kokati Venkata Bhaskara Rao
Journal:  IET Nanobiotechnol       Date:  2016-10       Impact factor: 1.847

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.